NCT05494086Recruiting
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer
Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomised Clinical Trial
Source: ClinicalTrials.gov · Last updated 13 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Dual-port laparoscopic gastrectomy (DPLG) has been widely performed in recent years for treating gastric cancers. The present study explore the safety and effect of dual-port laparoscopic distal gastrectomy (DPLDG).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 10 Jul 2022
- Start date
- 1 Aug 2022
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT05494086
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 1 Aug 2022 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients with prior neoadjuvant chemotherapy or radiation therapy; and (5)patients who need simultaneous surgical treatment for other malignant diseases.
Other illness
- patients with a history of upperabdominal surgery;
- patients with other histories of malignant diseases within 5 years;
Other
- patients who presentedas an emergency case;
Who the study is looking for
- patients within 18--75 years old;
- patients with a preoperative pathological diagnosis of gastric adenocarcinoma;
- patients with a clinical tumor stage of T1N1,T2N0 according to the preoperative examinations (gastroscopy, ultrasound gastroscopy and computed tomography);
- patients with a plan to undergo laparoscopic distal gastrectomy and obtain R0 surgical results;
- patients without severe heart, liver, lung, or kidney dysfunction;
- patients with an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-1; and (7) patients with American Society of Anesthesiologists (ASA) I-II.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nanfang Hospital Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.